The first tests in people of a vaccine that may slow or prevent the devastation of Alzheimer’s disease have so far shown that the approach is safe, scientists announced this week at a Washington, D.C., meeting. It’s still too early to gauge whether the vaccine actually works, however, say the researchers.
Newly reported animal tests added to the cautious optimism about the new vaccine strategy.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.